Breaking News - The Fly

Open Search

ALPMY

Astellas Pharma

$

()

Takeda, Astellas Pharma and Sumitomo Mitsui to establish joint venture company

TAK , ALPMY , SMFG

4/22/2024 - 05:21am

Astellas Pharma's Iveric Bio receives permanent J-code for IZERVAY

ALPMY

3/26/2024 - 08:32am

Astellas Pharma announces Japan's MHLW approved VYLOY

ALPMY

3/26/2024 - 08:03am

Astellas Pharma receives positive CHMP opinion for XTANDI

ALPMY

3/22/2024 - 08:01am

HP Asset Upcycling Services selected by Astellas Pharma for sustainability goals

HPE , ALPMY

3/14/2024 - 06:08am

FibroGen, AstraZeneca terminate U.S./RoW roxadustat collaboration agreement

FGEN , AZN , ALPMY

2/26/2024 - 16:15pm

Astellas Pharma announces changes to its management structure

ALPMY

2/6/2024 - 18:41pm

Astellas Pharma announces strategic collaboration with Mass General Brigham

ALPMY

1/30/2024 - 18:32pm

EMA validates Type II variation application for Padcev-Keytruda combination

PFE , ALPMY

1/26/2024 - 12:01pm

FDA says it cannot approve Astellas BLA for zolbetuximab by PDUFA action date

ALPMY

1/8/2024 - 18:35pm

Astellas, Elpiscience enter license agreement for bi-specific macrophage engager

ALPMY

12/28/2023 - 05:15am

Pfizer, Astellas Pharma announce FDA approval for Padcev

PFE , ALPMY

12/15/2023 - 17:05pm

Astellas Pharma's fezolinetant shows efficacy in Phase 3b VMS trial

ALPMY

11/29/2023 - 18:35pm

Astellas Pharma, Pfizer announce FDA approval of Xtandi sNDA

ALPMY , PFE

11/17/2023 - 05:36am

Astellas Pharma to acquire Propella Therapeutics for roughly $175M

ALPMY

11/15/2023 - 18:39pm